Memorandum of Understanding Between the Food and Drug Administration and the Food and Drug Administration Alumni Association, 55910-55914 [05-19016]

Download as PDF 55910 Federal Register / Vol. 70, No. 184 / Friday, September 23, 2005 / Notices (4) Increase information dissemination and training, and (5) Improve coordination across the radiological health community. II. Agenda On October 31, 2005, FDA is providing the opportunity for a number of stakeholder organizations to discuss how they can assist FDA in implementing the program and in addressing important public health problems. FDA and its stakeholders will discuss the following aspects of the radiological health plan overview: • Standards—Discussion will consider the following topics: Increased reliance by FDA on consensus radiation safety performance standards, the role of national and international standards, and the role of State regulations in assuring product safety and proper use. • Monitoring the Use of Radiation— Discussion will consider the following topics: The shift of CDRH’s focus from products to users, patients, and consumers; adverse event reporting; State program roles in ensuring appropriate use of radiation; facility quality assurance programs; and the establishment of a voluntary patient radiation dose reporting system for diagnostic imaging procedures that use ionizing radiation. This system could be used to monitor national exposure trends and provide a basis for establishing diagnostic reference levels of patient dose for use in facility quality improvement programs. • Monitoring the Industry— Discussion will consider the following topics: The shift of FDA emphasis from testing products, to inspecting manufacturers to assure quality manufacturing and products; the reduction of reporting requirements; and the development of electronic reporting methods. • Education—Discussion will consider education and training for manufacturers, regulators, and users. On November 1, 2005, FDA will hold concurrent discussion sessions throughout the day on the Standards, Monitoring, and Education topics to VerDate Aug<31>2005 15:21 Sep 22, 2005 Jkt 205001 provide further opportunity for stakeholder comment and discussion. FDA will provide an opportunity for comment during the public comment period for individuals and/or organizations on October 31, 2005. In addition, the agency will provide an opportunity to present individual viewpoints during the concurrent discussion sessions on November 1, 2005. FDA reserves the right to limit the time of speakers during the public comment periods. Dated: September 19, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. 05–19077 Filed 9–20–05; 3:31 pm] III. Registration Participants must register for the meeting by October 17, 2005. Acceptance will be on a first-come, firstserved basis. There will be no onsite registration and unregistered participants will not be added to the program. Please register online at https:// www.fda.gov/cdrh/meetings/ 120303.html. Persons without Internet access may register for the onsite meeting by calling 301–594–3309 by October 17, 2005. If you need special accommodations due to a disability, please fax information regarding those needs to Kaye Chesemore at 301–594–3306, at least 7 days in advance of the meeting. Memorandum of Understanding Between the Food and Drug Administration and the Food and Drug Administration Alumni Association IV. Request for Suggestions, Recommendations, and Materials FDA is particularly interested in receiving suggestions from stakeholders related to the topics listed previously in this document. Send suggestions or recommendations to the Division of Dockets Management (see ADDRESSES). FDA will place an additional copy of any material it receives in the docket for this document (2005N–0375). Suggestions, recommendations, and materials may be seen at the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday (see ADDRESSES). V. Transcripts Following the meeting, transcripts will be available for review at the Division of Dockets Management (see ADDRESSES). PO 00000 Frm 00096 Fmt 4703 Sfmt 4703 BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [FDA 225–04–8000] AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the Food and Drug Administration Alumni Association, Inc. The purpose of this MOU is to establish a greater collaboration between FDA and the Food and Drug Administration Alumni Association, Inc., regarding FDAs 2006 Centennial Observance. The agreement became effective July 28, 2004. DATES: FOR FURTHER INFORMATION CONTACT: Mary Hitch, Senior Advisor, Office of External Relations (HF–10), 5600 Fishers Lane, Rockville, MD 20857, 301–827–4406. In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU. SUPPLEMENTARY INFORMATION: Dated: September 8, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. BILLING CODE 4160–01–S E:\FR\FM\23SEN1.SGM 23SEN1 VerDate Aug<31>2005 15:21 Sep 22, 2005 Jkt 205001 PO 00000 Frm 00097 Fmt 4703 Sfmt 4725 E:\FR\FM\23SEN1.SGM 23SEN1 55911 EN23SE05.068</GPH> Federal Register / Vol. 70, No. 184 / Friday, September 23, 2005 / Notices VerDate Aug<31>2005 Federal Register / Vol. 70, No. 184 / Friday, September 23, 2005 / Notices 15:21 Sep 22, 2005 Jkt 205001 PO 00000 Frm 00098 Fmt 4703 Sfmt 4725 E:\FR\FM\23SEN1.SGM 23SEN1 EN23SE05.069</GPH> 55912 VerDate Aug<31>2005 15:21 Sep 22, 2005 Jkt 205001 PO 00000 Frm 00099 Fmt 4703 Sfmt 4725 E:\FR\FM\23SEN1.SGM 23SEN1 55913 EN23SE05.070</GPH> Federal Register / Vol. 70, No. 184 / Friday, September 23, 2005 / Notices 55914 Federal Register / Vol. 70, No. 184 / Friday, September 23, 2005 / Notices BILLING CODE 4160–01–C DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration [CFDA 93.223] Cooperative Agreement for Border Health Best Practices Office of Rural Health Policy, HRSA, DHHS. ACTION: Notice of Single Source Award. AGENCY: VerDate Aug<31>2005 15:21 Sep 22, 2005 Jkt 205001 SUMMARY: The Office of Rural Health Policy (ORHP), in cooperation with the Office of Global Health Affairs (OGHA), Office of Minority Health (OMH), Office on Women’s Health (OWH), and Centers for Disease Control and Prevention (CDC) will award a one year single source award to the U.S.-Mexico Border Health Association (USMBHA) to identify and promote best practices in border communities. As defined in the La Paz Agreement, the border region is 100 km north and south of the international boundary line between the United States and Mexico. Funds will be used on both sides of the U.S.Mexico border for the development of PO 00000 Frm 00100 Fmt 4703 Sfmt 4703 activities under the second annual Border Binational Health Week (October 10–16, 2005). FOR FURTHER INFORMATION CONTACT: Elizabeth Rezai-zadeh, Office of Rural Health Policy, Room 9A–55, 5600 Fishers Lane, Rockville, MD 20857. Telephone: 301–443–4107. E-mail: erezai@hrsa.gov. SUPPLEMENTARY INFORMATION: Intended Recipient of the Award U.S.-Mexico Border Health Association in El Paso, TX. Amount of the Award $383,000. E:\FR\FM\23SEN1.SGM 23SEN1 EN23SE05.071</GPH> [FR Doc. 05–19016 Filed 9–22–05; 8:45 am]

Agencies

[Federal Register Volume 70, Number 184 (Friday, September 23, 2005)]
[Notices]
[Pages 55910-55914]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-19016]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[FDA 225-04-8000]


Memorandum of Understanding Between the Food and Drug 
Administration and the Food and Drug Administration Alumni Association

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
a memorandum of understanding (MOU) between FDA and the Food and Drug 
Administration Alumni Association, Inc. The purpose of this MOU is to 
establish a greater collaboration between FDA and the Food and Drug 
Administration Alumni Association, Inc., regarding FDAs 2006 Centennial 
Observance.

DATES: The agreement became effective July 28, 2004.

FOR FURTHER INFORMATION CONTACT: Mary Hitch, Senior Advisor, Office of 
External Relations (HF-10), 5600 Fishers Lane, Rockville, MD 20857, 
301-827-4406.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which 
states that all written agreements and MOUs between FDA and others 
shall be published in the Federal Register, the agency is publishing 
notice of this MOU.

    Dated: September 8, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
BILLING CODE 4160-01-S

[[Page 55911]]

[GRAPHIC] [TIFF OMITTED] TN23SE05.068


[[Page 55912]]


[GRAPHIC] [TIFF OMITTED] TN23SE05.069


[[Page 55913]]


[GRAPHIC] [TIFF OMITTED] TN23SE05.070


[[Page 55914]]


[GRAPHIC] [TIFF OMITTED] TN23SE05.071

[FR Doc. 05-19016 Filed 9-22-05; 8:45 am]
BILLING CODE 4160-01-C

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.